About Eisai Research Institute
|
About Eisai Research Institute |
Eisai Research Institute (ERI), as a subsidiary
of Eisai
Co., Ltd. of Japan, combines the intimate atmosphere of a small
company (~ 200 employees) with the global
resources of an international
pharmaceutical company, allowing for efficient project advancement
and the opportunity for employees to contribute to all aspects of
the
drug discovery and development process. These qualities provide
a unique setting that emphasizes and challenges its scientists' talents
and creativity.
ERI specializes in the discovery and development of novel pharmaceutical
therapies for cancer, inflammation and immunological disorders.
ERI has discovered novel therapeutic agents currently in development
for the treatment of inflammatory diseases and cancer.
For information about Eisai's products, please go to our sales and
marketing website www.eisai.com